Redmile Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Sell |
1,448,040
-1,767,986
| -55% | -$12.7M | 1.11% | 21 |
|
|
2025
Q1 | $19.3M | Sell |
3,216,026
-338,810
| -10% | -$2.03M | 1.82% | 18 |
|
|
2024
Q4 | $27.7M | Sell |
3,554,836
-929,544
| -21% | -$7.25M | 1.93% | 20 |
|
|
2024
Q3 | $48.4M | Sell |
4,484,380
-315,593
| -7% | -$3.41M | 2.85% | 13 |
|
|
2024
Q2 | $40.5M | Buy |
4,799,973
+837,371
| +21% | +$7.06M | 2.45% | 14 |
|
|
2024
Q1 | $26.6M | Buy |
3,962,602
+1,048,580
| +36% | +$7.05M | 0.98% | 36 |
|
|
2023
Q4 | $17.1M | Buy |
2,914,022
+860,689
| +42% | +$5.06M | 0.61% | 43 |
|
|
2023
Q3 | $20M | Hold |
2,053,333
| – | – | 0.95% | 32 |
|
|
2023
Q2 | $24.3M | Buy |
+2,053,333
| New | +$24.3M | 0.93% | 32 |
|